Why is Cerebras Systems stock sliding to a new 52-week low today?

Cerebras shares fell 10.0% to $147.76, a new 52-week low, amid reports that OpenAI’s GPT-6.1 Sol inference tier uses Nvidia GPUs and Microsoft’s plan to make its Maia chips the primary inference system for its products from 2027. About 19.4 million shares are set to become eligible for sale around October 14, adding to supply concerns; insiders collectively sold hundreds of millions of dollars’ worth of shares over the past quarter. The stock is now more than 60% below its $386.34 all-time high, while analyst consensus remains Moderate Buy despite recent price-target cuts.

Analysis

The key risk is not that one inference tier uses a different processor; it is whether this weakens the expected economics or strategic importance of Cerebras’s OpenAI relationship. A workload-level substitution does not establish that the broader agreement is displaced: verify committed capacity, deployment mix, utilization, and any minimum-payment or cancellation terms before treating the contract as impaired. Conversely, if OpenAI routes more production inference to Nvidia, Cerebras could face both lower utilization and weaker proof that its architecture can win at scale.

Near term (days), the unlock can amplify price moves through incremental supply and constrained liquidity. That is a positioning catalyst, not evidence by itself of deteriorating operations; insider sales also need to be separated by seller and remaining holdings. Over 1–3 months, contract disclosures and evidence of customer diversification matter more than the unlock. Over 6–18 months, Microsoft’s in-house inference ambitions add a credible substitution path, but execution, software compatibility, and total cost of ownership determine whether this becomes material. Microsoft may gain control over workload economics, while its silicon plans are not yet proof of lower consolidated costs. Nvidia is a relative beneficiary if customers continue using its deployed ecosystem, though one reported workload is not enough to revise its outlook.

Contrarian risk: the share-price decline may already discount substantial contract impairment. A reflexive short into an unlock can be vulnerable to supply absorption or clarifying contract evidence. The thesis weakens if Cerebras demonstrates sustained utilization and customer wins outside OpenAI; it strengthens with adverse contract economics or further production workload shifts.

Key Decisions for Investors

• Avoid initiating a fresh long in CBRS before the unlock supply is absorbed and contract economics are clearer; treat any post-unlock stabilization as a signal to reassess, not an automatic buy.
• For a tactical bearish position, consider a defined-risk CBRS put spread only if options liquidity and implied volatility are acceptable; otherwise wait for a post-unlock breakdown confirmed by trading volume. Exit or reassess if the stock reclaims its pre-unlock level and Cerebras verifies durable OpenAI utilization.
• Do not infer a material NVDA earnings upgrade from this single workload report. Keep NVDA as a relative-quality exposure rather than a direct event trade; monitor whether additional named production workloads shift to Nvidia.
• Track Cerebras filings and disclosures for lockup seller identities, shares actually offered, OpenAI contract minimums/cancellation terms, and customer utilization. These missing data points determine whether the move is mostly technical or a fundamental repricing.